Pfizer Buys Stake in Valneva to Advance Lyme Disease Vaccine

Pfizer inked an Equity Subscription Agreement with Saint-Herblain, France-based Valneva, updating a collaboration and license deal for a Lyme disease vaccine that was announced in April.